Use of an algorithm applied to urine drug screening to assess adherence to a hydrocodone regimen

Journal of Clinical Pharmacy and Therapeutics

Volumn 36, Issue 2, 2011, Pages 200-207

  Couto, J E ^a   Webster, L ^b   Romney, M C ^a   Leider, H L ^c   Linden, A ^d  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Lifetree Clinical Research and Lifetree Pain Clinical   (United States)

^c Ameritox Ltd   (United States)

^d LINDEN CONSULTING GROUP   (United States)

Author keywords

algorithm; hydrocodone; medication adherence; urine drug testing

Indexed keywords

HYDROCODONE; NALTREXONE;

ADULT; ALGORITHM; ARTICLE; CONFIDENCE INTERVAL; CORRELATION COEFFICIENT; DRUG ANTAGONISM; DRUG DISCRIMINATION; DRUG DOSE ESCALATION; DRUG DOSE REGIMEN; DRUG SCREENING; DRUG URINE LEVEL; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; HUMAN EXPERIMENT; LEAN BODY WEIGHT; MALE; NORMAL HUMAN; PATIENT COMPLIANCE; RELATIVE DENSITY; STEADY STATE;

ADULT; ALGORITHMS; ANALGESICS, OPIOID; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYDROCODONE; IMMUNOASSAY; MALE; MEDICATION ADHERENCE; NALTREXONE; NARCOTIC ANTAGONISTS; SUBSTANCE ABUSE DETECTION; YOUNG ADULT;

EID: 79952275860     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2010.01236.x     Document Type: Article

References (23)

1. IMS (2009) U.S. Prescription Drug Sales Grow Slowly; Hydrocodone Most Prescribed. Available at: (accessed 13 July 2009).
2. Office of Diversion Control (2008) National Forensic Laboratory Information System, Midyear Report 2008. Available at: (accessed 13 July 2009).
3. Substance Abuse & Mental Health Services Administration (2008) National Estimates from the Drug Abuse Warning Network. Available at: (accessed 13 July 2009).
4. Chou R, Fanciullo GJ, Fine PG, et al. (2009) Opioid treatment guidelines: clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. Journal of Pain, 10, 113-130.
5. Katz N, Fanciullo GJ, (2002) Role of urine toxicology testing in the management of chronic opioid therapy. Clinical Journal of Pain, 18, S76-S82. (Pubitemid 34815397)
6. Tellioglu T, (2008) The use of urine drug testing to monitor patients receiving chronic opioid therapy for persistent pain conditions. Medicine and Health, Rhode Island, 91, 279-282.
7. Kell MJ, (1994) Utilization of plasma and urine methadone concentrations to optimize treatment in maintenance clinics: I. measurement for a clinical setting. Journal of Addictive Diseases, 13, 5-26. (Pubitemid 24122147)
8. Kell MJ, (1995) Utilization of plasma and urine methadone concentration measurements to limit narcotics use in methadone maintenance patients: II. generation of plasma concentration response curves. Journal of Addictive Diseases, 14, 85-108.
9. Couto J, Webster L, Romney M, et al. (2009) Using an algorithm applied to urine drug screening to assess adherence to an OxyContin® regimen. Journal of Opioid Management, 5, 359-364.
10. Lin LI, (1989) A concordance correlation coefficient to evaluate reproducibility. Biometrics, 45, 255-268.
11. Lin LIK, (2000) A note on the concordance correlation coefficient. Biometrics, 56, 324-325.
12. Bonett DG, Price RM, (2002) Statistical inference for a linear function of medians: confidence intervals, hypothesis testing, and sample size requirements. Psychological Methods, 7, 370-383.
13. Price RM, Bonett DG, (2001) Estimating the variance of the sample median. Journal of Statistical Computation and Simulation, 68, 295-305.
14. Price RM, Bonett DG, (2002) Distribution-free confidence intervals for difference and ratio of medians. Journal of Statistical Computation and Simulation, 72, 119-124. (Pubitemid 36844177)
15. Newson R, (2002) Parameters behind "nonparametric" statistics: Kendall's tau, Somers' D and median differences. The Stata Journal, 2, 45-64.
16. Newson R, (2006) Confidence intervals for rank statistics: Somers' D and extensions. The Stata Journal, 6, 309-334. (Pubitemid 44505049)
17. Steichen TJ, Cox NJ, (1998) Concordance correlation coefficient. Stata Technical Bulletin, 43, 35-39.
18. Steichen TJ, Cox NJ, (2008) Software update for concord. Stata Journal, 8, 594.
19. Speaking Stata (2004) Graphing Agreement and Disagreement. Statistical Software Components. Available at: = (accessed 1 May 2009).
20. BPMEDIAN (2009) Stata Module to Compute Bonett-Price Confidence Intervals for Medians and Their Contrasts. Statistical Software Components (SSC). Available at: (accessed 3 June 2009).
21. SOMERSD (2009) Stata Module to Calculate Kendall's tau-a, Somers' D and Median Differences. Statistical Software Components (SSC). Available at: (accessed 2 December 2009).
22. Bradford LD, (2002) CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics, 3, 229-243. (Pubitemid 34223859)
23. Evans WE, Relling MV, Rahman A, et al. (1993) Genetic basis for a lower prevalence of deficient CYP2D6 oxidative drug metabolism phenotypes in Black Americans. Journal of Clinical Investigation, 91, 2150-2154. (Pubitemid 23141491)